CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: July 13, 2007
Result type: Reports
Project Number: SR0104-000
Product Line: Reimbursement Review

Generic Name: Idursulfase

Brand Name: Elaprase

Manufacturer: Shire Human Genetic Therapies, Inc.

Therapeutic Area: Mucopolysarccharidosis II (MPS II), Hunter Syndrome

Indications: Mucopolysaccharidosis II (MPS II), Hunter Syndrome

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 19, 2007

Recommendation Type: Do not list